This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodriguez, C. O. Articles by Gandhi, V. Search for Related Content PubMed PubMed Citation Articles by Rodriguez, C. O., Jr. Articles by Gandhi, V.

Arabinosylguanine-induced Apoptosis of T-Lymphoblastic Cells

Incorporation into DNA Is a Necessary Step¹

Departments of Clinical Investigation and Leukemia [V.G.], The University of Texas M. D. Anderson Cancer Center, and The Graduate School of Biomedical Sciences, Houston, Texas 77030

9-ß-D-Arabinosylguanine (ara-G) is a recently introduced and effective treatment for T-cell acute lymphoblastic leukemia, but how ara-G and ara-G triphosphate (ara-GTP) kill cells is not known. We hypothesized that, in cycling T-lymphoblastoid cells, ara-G may act directly by incorporation into DNA, which may lead to apoptosis. Hence, blocking the incorporation of ara-G monophosphate (ara-GMP) into DNA may prevent apoptosis. To test this hypothesis, we performed experiments in a T-lymphoblastic leukemia cell line (CCRF-CEM) after synchronization with a double aphidicolin block. Intracellular accumulation of ara-GTP was neither cell cycle dependent nor affected by aphidicolin (53 ± 5 µM/h without aphidicolin, 50 ± 5 µM/h with aphidicolin). Cells at the G₁-S boundary accumulated 75 ± 7 µM ara-GTP with minimal incorporation into DNA (5 ± 2 pmol ara-GMP/mg DNA) and had little biochemical or morphological evidence of apoptosis. In marked contrast, cells in S phase had significantly more ara-G incorporated into DNA (24 ± 4 pmol ara-GMP/mg DNA), although the cytosolic concentration of ara-GTP (85 ± 7 µM) was similar to that in the G₁-enriched population. In the S-phase cells, there was a corresponding increase in apoptosis (measured as high molecular weight DNA fragmentation and morphological changes), and the incorporation of ara-GTP into DNA resulted in a >95% inhibition of DNA synthesis. There was a direct linear relationship between the number of cells in S phase and both the total number of ara-GMP molecules in DNA and the inhibition of DNA synthesis. Blocking of ara-GTP incorporation into S-phase DNA abolished biochemical and morphological features of apoptosis, even in the presence of cytotoxic level of intracellular ara-GTP. Taken together, these data demonstrate that the incorporation of ara-GTP into DNA is the critical event that mediates the induction of apoptosis in CCRF-CEM cells.

This article has been cited by other articles:

				D. F Kisor Nelarabine: A Nucleoside Analog with Efficacy in T-Cell and Other Leukemias Ann. Pharmacother., June 1, 2005; 39(6): 1056 - 1063. [Abstract] [Full Text] [PDF]

				C. O. Rodriguez Jr, C. M. Stellrecht, and V. Gandhi Mechanisms for T-cell selective cytotoxicity of arabinosylguanine Blood, September 1, 2003; 102(5): 1842 - 1848. [Abstract] [Full Text] [PDF]

				C. O. Rodriguez Jr., B. S. Mitchell, M. Ayres, S. Eriksson, and V. Gandhi Arabinosylguanine Is Phosphorylated by Both Cytoplasmic Deoxycytidine Kinase and Mitochondrial Deoxyguanosine Kinase Cancer Res., June 1, 2002; 62(11): 3100 - 3105. [Abstract] [Full Text] [PDF]

				V. Gandhi, W. Plunkett, S. Weller, M. Du, M. Ayres, C. O. Rodriguez Jr, P. Ramakrishna, G. L. Rosner, J. P. Hodge, S. O'Brien, et al. Evaluation of the Combination of Nelarabine and Fludarabine in Leukemias: Clinical Response, Pharmacokinetics, and Pharmacodynamics in Leukemia Cells J. Clin. Oncol., April 15, 2001; 19(8): 2142 - 2152. [Abstract] [Full Text] [PDF]